Which hedge funds own TVTX? TRAVERE THERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
9 of the hedge funds tracked by WhaleCreep disclosed a position in TVTX (TRAVERE THERAPEUTICS INC) in their Q2 2026 13F filings, worth $312.6m in total. The largest holder by portfolio weight is Renaissance Technologies LLC at 0.1% of its book. 3 managers opened a new position this quarter: Point72 Asset Management LP, Polen Capital Management, Millennium Management. 3 exited: D. E. Shaw & Co, Farallon Capital Management, RA Capital Management.
9tracked managers holding
3opened this quarter
3exited this quarter
Which hedge funds hold TVTX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Q2 2026 | 0.1% | $104.1m | 1,833,079 | -7% | reduced |
| Marshall Wace | Q2 2026 | 0.1% | $75.7m | 1,333,207 | 647% | added |
| D. E. Shaw & Co | Q2 2026 | 0.1% | $81.8m | 1,440,469 | 72% | added |
| Woodline Partners | Q2 2026 | 0.0% | $14.4m | 254,054 | -16% | reduced |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $27.2m | 478,860 | – | new |
| Polen Capital Management | Q2 2026 | 0.0% | $1.9m | 34,315 | – | new |
| Millennium Management | Q2 2026 | 0.0% | $4.8m | 84,713 | – | new |
| Tudor Investment | Q2 2026 | 0.0% | $338.3k | 5,955 | -82% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $2.2m | 38,460 | -70% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| D. E. Shaw & Co | 1.0% | $48.4m |
| Farallon Capital Management | 0.0% | $356.5k |
| RA Capital Management | 0.7% | $22.2m |
How has hedge fund ownership of TVTX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 9 | $312.6m |
| Q1 2026 | 8 | $173.3m |
| Q4 2025 | 5 | $107.3m |
| Q3 2025 | 6 | $85.4m |
| Q2 2025 | 6 | $67.0m |
| Q1 2025 | 6 | $148.6m |
| Q4 2024 | 6 | $164.2m |
| Q3 2024 | 4 | $94.8m |
| Q2 2024 | 4 | $34.5m |
| Q1 2024 | 3 | $30.7m |
| Q4 2023 | 5 | $52.4m |
| Q3 2023 | 6 | $53.5m |
| Q2 2023 | 4 | $75.1m |
| Q1 2023 | 5 | $91.2m |
| Q4 2022 | 4 | $119.9m |
| Q3 2022 | 6 | $182.7m |
Counts every tracked manager that disclosed TVTX in that quarter's filing, including managers that have since stopped filing.